• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

FDA’s Carvykti Approval Gives Patients Whose Myeloma Has ‘Failed Everything’ Another Chance to Attack the Disease

by | Mar 10, 2022 | Uncategorized

Source: Cure Today articles The recent FDA approval of the CAR-T cell therapy Carvykti represents a life-changing advancement for patients with multiple myeloma whose disease progressed after countless other treatments, according to an expert. Read...

Combination Maintenance Therapy After Stem Cell Transplant May Prolong Survival in Multiple Myeloma

by | Mar 9, 2022 | Uncategorized

Source: Cure Today articles Maintenance therapy with Ninlaro and Revlimid in patients with recently diagnosed multiple myeloma who underwent a stem cell transplant may safely improve survival, although more research is needed especially in high-risk patients. Read...

How a Nutritious Diet May Help During Myeloma Treatment

by | Mar 9, 2022 | Uncategorized

Source: Cure Today articles Maintaining a healthy diet during treatment may help combat side effects. Read More

Socioeconomic Gaps Can Lead to Poorer Outcomes in Multiple Myeloma

by | Mar 9, 2022 | Uncategorized

Source: Cure Today articles Although multiple myeloma survival rates have improved over the past 20 years, the survival gap among socioeconomic groups has widened. Read More

Long-Term Care of Myeloma May Not Be ‘One-Stop-Shop,’ Multidisciplinary Approach Can Help

by | Mar 3, 2022 | Uncategorized

Source: Cure Today articles As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about treating myeloma as a chronic disease and how the multidisciplinary approach to care can assist in challenges, like financial toxicity. Read...

Advocate Emphasizes ‘Investing in Yourself’ to Improve Patient-Physician Communication

by | Mar 3, 2022 | Uncategorized

Source: Cure Today articles As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about improving patient-physician communication throughout myeloma care. Read More
« Older Entries
Next Entries »

Recent Content

  • A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast
  • Talquetamab and Teclistamab Achieve Deep, Durable Responses in Patients With Relapsed, Refractory Multiple Myeloma
  • Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study
  • Fixed-Dose Subcutaneous Sarclisa Combo is Non-Inferior to IV Sarclisa in R/R Myeloma
  • Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma
  • Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma
  • IVIG Supplementation Reduces Infection Risk in Patients With Multiple Myeloma Receiving Teclistamab
  • Combination induces durable responses in advanced multiple myeloma
  • Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes
  • Peroxiredoxin 6 maintains mitochondrial homeostasis and promotes tumor progression through ROS/JNK/p38 MAPK signaling pathway in multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT